British drugmaker AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn drug Prilosec in the United States.
The agreements effectively resolve all pending claims filed against the company for failing to warn patients about the risk of contracting chronic kidney disease and related issues, except for one in Louisiana, AstraZeneca said - the trial for which is scheduled in April next year.Apology sought from Dublin school for employing former Nazi SS officer as a teacher
‘My mom always had to ask my dad for money and I remember thinking I never wanted to have to rely on anyone else for money’For years, Ireland has been doing something just as economically stupid as Brexit